The meth crisis is worse than ever, but new treatments could be near
Monoclonal antibodies are one of several promising new approaches to battling a type of addiction that had defied medication treatment.
Stay updated with breaking news from Brooks Gentry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Monoclonal antibodies are one of several promising new approaches to battling a type of addiction that had defied medication treatment.
In drug treatment in L.A. County, "contingency management" remains uncommon, despite strong evidence that it can help people stop using stimulants.
The National Institutes of Drug Abuse has awarded $13.8 million to UAMS for the clinical trial of a drug that counters the effects of using methamphetamine.
A drug that has the potential to be the only pharmaceutical treatment for methamphetamine drug abuse will head into a phase two clinical trial at the University of Arkansas for Medical Sciences after it was awarded a $13.8 million grant from the National Institutes of Health's drug abuse institute.
The federal grant money will fund a mid-stage clinical trial of a drug that could help meth users break their addiction.